Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$270.00
▼ $3.14 (−1.15%) today
Markets closed · 6:33am ET

JNJ Coverage

Page 71
8:31am ET
Companies and Brands

Avon Nabs CEO from J&J (AVP, JNJ)

The board of directors of Avon Products Inc. (NYSE: AVP) have named Sherilyn McCoy as the company’s new CEO. McCoy has spent virtually her entire professional career with Johnson & Johnson (NYSE:…

Paul Ausick
6:31am ET
Media

Media Digest (3/15/2012) Reuters, WSJ, FT, Bloomberg

RealtyTrac says foreclosure notices rose last month. (Reuters) The U.S. and UK discuss releasing strategic oil reserves to bring down fuel prices. (Reuters) Volcker says new inflation would be harmful to the…

Douglas A. McIntyre
11:13am ET
Investing

J&J Losing Warren Buffett Support (JNJ, BRK.A)

Johnson & Johnson (NYSE: JNJ) is a company that has lost much of a formerly great reputation.  Warren Buffett even admitted that today.  In an on and off 3-hour interview earlier this…

Jon C. Ogg
6:25pm ET
Investing

Bill Weldon Replaced As Johnson & Johnson CEO

As Bill Weldon leaves the headquarters of Johnson & Johnson (NYSE: JNJ), probably many years from now, he will know that his tenure will be remembered for hip replacement and children’s Tylenol recalls…

JNJ
Douglas A. McIntyre